
Biopharmaceuticals Contract Manufacturing Service Industry Research Report 2025
Description
Summary
According to APO Research, The global Biopharmaceuticals Contract Manufacturing Service market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biopharmaceuticals Contract Manufacturing Service include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals Contract Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals Contract Manufacturing Service.
The Biopharmaceuticals Contract Manufacturing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceuticals Contract Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Biopharmaceuticals Contract Manufacturing Service Segment by Company
WuXi Biologics
Takeda
Sanofi
Johnson & Johnson
Merck
Roche
Lonza Group
Pfizer
GlaxoSmithKline
AbbVie
Samsung BioLogics
Rentschler Biotechnologie
ProBioGen
Novo Medi Sciences
JRS Pharma
Galentic Pharma
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
AGC Biologics
Biopharmaceuticals Contract Manufacturing Service Segment by Type
Packaging
Process Development
Manufacturing
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Biopharmaceuticals Contract Manufacturing Service market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biopharmaceuticals Contract Manufacturing Service include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals Contract Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals Contract Manufacturing Service.
The Biopharmaceuticals Contract Manufacturing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceuticals Contract Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Biopharmaceuticals Contract Manufacturing Service Segment by Company
WuXi Biologics
Takeda
Sanofi
Johnson & Johnson
Merck
Roche
Lonza Group
Pfizer
GlaxoSmithKline
AbbVie
Samsung BioLogics
Rentschler Biotechnologie
ProBioGen
Novo Medi Sciences
JRS Pharma
Galentic Pharma
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
AGC Biologics
Biopharmaceuticals Contract Manufacturing Service Segment by Type
Packaging
Process Development
Manufacturing
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
131 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Biopharmaceuticals Contract Manufacturing Service by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 Packaging
- 2.2.3 Process Development
- 2.2.4 Manufacturing
- 2.3 Biopharmaceuticals Contract Manufacturing Service by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Vaccines
- 2.3.3 Peptides and Protein
- 2.3.4 Biosimilars
- 2.3.5 Antibodies
- 2.3.6 Others
- 2.4 Assumptions and Limitations
- 3 Biopharmaceuticals Contract Manufacturing Service Breakdown Data by Type
- 3.1 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Type (2020-2025)
- 3.2 Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Type (2026-2031)
- 4 Biopharmaceuticals Contract Manufacturing Service Breakdown Data by Application
- 4.1 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Application (2020-2025)
- 4.2 Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Biopharmaceuticals Contract Manufacturing Service Market Perspective (2020-2031)
- 5.2 Global Biopharmaceuticals Contract Manufacturing Service Growth Trends by Region
- 5.2.1 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Region (2020-2025)
- 5.2.3 Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Region (2026-2031)
- 5.3 Biopharmaceuticals Contract Manufacturing Service Market Dynamics
- 5.3.1 Biopharmaceuticals Contract Manufacturing Service Industry Trends
- 5.3.2 Biopharmaceuticals Contract Manufacturing Service Market Drivers
- 5.3.3 Biopharmaceuticals Contract Manufacturing Service Market Challenges
- 5.3.4 Biopharmaceuticals Contract Manufacturing Service Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Biopharmaceuticals Contract Manufacturing Service Players by Revenue
- 6.1.1 Global Top Biopharmaceuticals Contract Manufacturing Service Players by Revenue (2020-2025)
- 6.1.2 Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Players (2020-2025)
- 6.2 Global Biopharmaceuticals Contract Manufacturing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biopharmaceuticals Contract Manufacturing Service Head Office and Area Served
- 6.4 Global Biopharmaceuticals Contract Manufacturing Service Players, Product Type & Application
- 6.5 Global Biopharmaceuticals Contract Manufacturing Service Manufacturers Established Date
- 6.6 Global Biopharmaceuticals Contract Manufacturing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 7.2 North America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2020-2025)
- 7.4 North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 8.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2020-2025)
- 8.4 Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 9.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 10.2 South America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2020-2025)
- 10.4 South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 11.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 WuXi Biologics
- 12.1.1 WuXi Biologics Company Information
- 12.1.2 WuXi Biologics Business Overview
- 12.1.3 WuXi Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.1.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.1.5 WuXi Biologics Recent Developments
- 12.2 Takeda
- 12.2.1 Takeda Company Information
- 12.2.2 Takeda Business Overview
- 12.2.3 Takeda Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.2.4 Takeda Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.2.5 Takeda Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.3.4 Sanofi Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Information
- 12.4.2 Johnson & Johnson Business Overview
- 12.4.3 Johnson & Johnson Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.4.4 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.4.5 Johnson & Johnson Recent Developments
- 12.5 Merck
- 12.5.1 Merck Company Information
- 12.5.2 Merck Business Overview
- 12.5.3 Merck Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.5.4 Merck Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.5.5 Merck Recent Developments
- 12.6 Roche
- 12.6.1 Roche Company Information
- 12.6.2 Roche Business Overview
- 12.6.3 Roche Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.6.4 Roche Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.6.5 Roche Recent Developments
- 12.7 Lonza Group
- 12.7.1 Lonza Group Company Information
- 12.7.2 Lonza Group Business Overview
- 12.7.3 Lonza Group Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.7.4 Lonza Group Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.7.5 Lonza Group Recent Developments
- 12.8 Pfizer
- 12.8.1 Pfizer Company Information
- 12.8.2 Pfizer Business Overview
- 12.8.3 Pfizer Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.8.4 Pfizer Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.8.5 Pfizer Recent Developments
- 12.9 GlaxoSmithKline
- 12.9.1 GlaxoSmithKline Company Information
- 12.9.2 GlaxoSmithKline Business Overview
- 12.9.3 GlaxoSmithKline Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.9.4 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.9.5 GlaxoSmithKline Recent Developments
- 12.10 AbbVie
- 12.10.1 AbbVie Company Information
- 12.10.2 AbbVie Business Overview
- 12.10.3 AbbVie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.10.4 AbbVie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.10.5 AbbVie Recent Developments
- 12.11 Samsung BioLogics
- 12.11.1 Samsung BioLogics Company Information
- 12.11.2 Samsung BioLogics Business Overview
- 12.11.3 Samsung BioLogics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.11.4 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.11.5 Samsung BioLogics Recent Developments
- 12.12 Rentschler Biotechnologie
- 12.12.1 Rentschler Biotechnologie Company Information
- 12.12.2 Rentschler Biotechnologie Business Overview
- 12.12.3 Rentschler Biotechnologie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.12.4 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.12.5 Rentschler Biotechnologie Recent Developments
- 12.13 ProBioGen
- 12.13.1 ProBioGen Company Information
- 12.13.2 ProBioGen Business Overview
- 12.13.3 ProBioGen Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.13.4 ProBioGen Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.13.5 ProBioGen Recent Developments
- 12.14 Novo Medi Sciences
- 12.14.1 Novo Medi Sciences Company Information
- 12.14.2 Novo Medi Sciences Business Overview
- 12.14.3 Novo Medi Sciences Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.14.4 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.14.5 Novo Medi Sciences Recent Developments
- 12.15 JRS Pharma
- 12.15.1 JRS Pharma Company Information
- 12.15.2 JRS Pharma Business Overview
- 12.15.3 JRS Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.15.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.15.5 JRS Pharma Recent Developments
- 12.16 Galentic Pharma
- 12.16.1 Galentic Pharma Company Information
- 12.16.2 Galentic Pharma Business Overview
- 12.16.3 Galentic Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.16.4 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.16.5 Galentic Pharma Recent Developments
- 12.17 FUJIFILM Diosynth Biotechnologies
- 12.17.1 FUJIFILM Diosynth Biotechnologies Company Information
- 12.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 12.17.3 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.17.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 12.18 Boehringer Ingelheim
- 12.18.1 Boehringer Ingelheim Company Information
- 12.18.2 Boehringer Ingelheim Business Overview
- 12.18.3 Boehringer Ingelheim Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.18.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.18.5 Boehringer Ingelheim Recent Developments
- 12.19 AGC Biologics
- 12.19.1 AGC Biologics Company Information
- 12.19.2 AGC Biologics Business Overview
- 12.19.3 AGC Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2020-2025)
- 12.19.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 12.19.5 AGC Biologics Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.